TITLE

HCV core antigen assay reliable, cost-effective monitoring tool

PUB. DATE
June 2015
SOURCE
PharmacoEconomics & Outcomes News;Jun2015, Vol. 730 Issue 1, p19
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses research being done on the cost effectiveness of hepatitis C core antigen assay in the monitoring of anti-viral therapy, which references a study by S. M. Kamal et al. published in the May 27, 2015 issue of the journal "Alimentary Pharmacology and Therapeutics."
ACCESSION #
103342926

 

Related Articles

  • HCV core antigen and HCV-RNA in HIV/HCV coinfected patients with different HCV genotypes. Garbuglia, Anna Rosa; Monachetti, Alessia; Galli, Claudio; Sabatini, Rosella; Ferreri, Monica Lucia; Capobianchi, Maria Rosaria; Bagnarelli, Patrizia // BMC Infectious Diseases;2014, Vol. 14 Issue 1, p1 

    Background A good correlation between HCV core antigen (HCVAg) and different HCV-RNA assays has been described, but little data are available in HCV/HIV co-infection. We aimed to evaluate HCVAg in comparison with HCV-RNA and to determine their kinetics during antiviral treatment in selected...

  • Removal of Hepatitis C Virus-Infected Cells by a Zymogenized Bacterial Toxin. Shapira, Assaf; Shapira, Shiran; Gal-Tanamy, Meital; Zemel, Romy; Tur-Kaspa, Ran; Benhar, Itai // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Hepatitis C virus (HCV) infection is a major cause of chronic liver disease and has become a global health threat. No HCV vaccine is currently available and treatment with antiviral therapy is associated with adverse side effects. Moreover, there is no preventive therapy for recurrent hepatitis...

  • Peginterferon-α-2a.  // Reactions Weekly;Jun2014, Vol. 1507 Issue 1, p25 

    An abstract of the article "Sustained virological response after 4 weeks of telaprevir, peginterferon, and ribavirin in an Asian patient with genotype 1 chronic hepatitis C and IL28B genotype CC," by N. presented.

  • New treatment for hepatitis C launched in the UK.  // Gastrointestinal Nursing;Sep2011, Vol. 9 Issue 7, p10 

    The article reports that Victrelis (boceprevir), the new antiviral drug to be licensed for the treatment of hepatitis C was launched in Great Britain recently, following approval by the European Medicines Agency.

  • Autoantibodies in Hepatitis C Virus-Related Chronic Liver Disease. Himoto, Takashi; Nishioka, Mikio // Hepatitis Monthly;Autumn2008, Vol. 8 Issue 4, p295 

    Persistent hepatitis C virus (HCV) infection evokes autoimmune response including production of autoantibodies and concomitant autoimmune disorders. Numerous types of autoantibodies such as non-organ-specific autoantibodies and liver-specific autoantibodies have been identified in sera of...

  • Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection. Missale, Gabriele; Pilli, Massimo; Zerbini, Alessandro; Penna, Amalia; Ravanetti, Lara; Barili, Valeria; Orlandini, Alessandra; Molinari, Atim; Fasano, Massimo; Santantonio, Teresa; Ferrari, Carlo // Gut;Jul2012, Vol. 61 Issue 7, p1076 

    Background: Hepatitis C virus (HCV) persistence is associated with impaired CD8 functions. Whether functional restoration of CD8 T cells chronically exposed to antigen can be obtained once the antigen is removed remains to be clarified. Objective: To determine whether clearance of HCV by...

  • Quantification and Functional Analysis of Plasmacytoid Dendritic Cells in Patients with Chronic Hepatitis C Virus Infection. Goutagny, Nadège; Vieux, Claude; Decullier, Evelyne; Ligeoix, Benolt; Epstein, Alberto; Trépo, Christian; Couzigou, Patrice; Inchauspé, Genevieve; Bain, Christine // Journal of Infectious Diseases;5/1/2004, Vol. 189 Issue 9, p1646 

    Background. Plasmacytoid dendritic cells (PDCs) are the major producers of interferon (IFN)-α within peripheral blood mononuclear cells (PBMCs). Methods. We analyzed whether chronic hepatitis C virus (HCV) infection could be linked to a defective function or number of PDCs. We evaluated the...

  • Surprisingly small effect of antiviral treatment in patients with hepatitis C. Falck-Ytter, Yngve; Kale, Hemangi; Mullen, Kevin D.; Sarbah, Steedman A.; Sorescu, Lucian; McCullough, Arthur J. // Annals of Internal Medicine;2/19/2002, Vol. 136 Issue 4, p288 

    Background: The effect and applicability of interferon-based antiviral therapies in the general population of persons with hepatitis C virus (HCV) infection are unknown.Objective: To determine the applicability and usefulness of anti-viral therapy in a metropolitan...

  • Telaprevir.  // Reactions Weekly;10/27/2012, Issue 1425, p34 

    The article describes the case of a 74-year-old woman who experienced perianal ulcerations while receiving telaprevir for chronic hepatitis C.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics